Bright Green Corp (BGXX)

[solidgold]

Bright Green Announces Appointment of Seamus McAuley, Chief Operating Officer of Bright Green, as Chief Executive Officer
Terry Rafih to remain as Executive Chairman of the Board

Appointment reinforces Company’s strategy to build out its team to deliver on the development of cannabis-based medicines and products, as well as its greenhouse expansion plans

The Company confirms the receipt of its first funds from its EB-5 program

[solidgold]

Investor Relation. Bright Green Corporation
Bright Green is a first-mover in the U.S. federally-authorized cannabis space. We are one of the very few companies selected by the US government to grow, manufacture and sell – legally under federal and state laws – cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. Through legal partnerships with state and federal agencies – including a Memorandum of Agreement (MOA) from the U.S. Drug Enforcement Administration (DEA) – we can operate at a scale that is unprecedented in this emerging market.

[Stevenvegas]

I will be exiting BGXX. didn't like that PR 140s

[Stevenvegas]

BGXX making the moves today. See if she breaks that recent 180 high from 2 days ago. They should follow up on that PR

[harry crumb]

Thanx

[TheFinalCD]

Bright Green Corporation's (NASDAQ:BGXX) market cap increased by US$154m, insiders receive a 74% cut

https://finance.yahoo.com/news/bright-green-corporations-nasdaq-bgxx-110904593.html

[harry crumb]

1.25???

[TheFinalCD]

1.25

[harry crumb]

Premarket looking good

[harry crumb]

Load an have patience! Enough said. $$$

[Babubd]

This is gonna be one of the greatest runners of out time. 52-wk high is $58!! NOT selling till $50!!

Bright Green Announces Plans to Raise $500 Million Under EB-5 Capital Program
Capital raised from EB-5 Program projected to generate over 7,100 direct and induced jobs in New Mexico and across the U.S.

Funds will be used to further develop Bright Green’s world-class production and drug manufacturing facilities in New Mexico, as well as to support drug research, development, and associated FDA clinical trials

Bright Green to issue stock through EB-5 Program at a price of $39.99 per share, subject to customary regulatory approvals

https://ca.finance.yahoo.com/news/bright-green-announces-plans-raise-140000169.html

[Babubd]

This is gonna be one of the greatest runners of out time. 52-wk high is $58!! NOT selling till $50!!

Bright Green Announces Plans to Raise $500 Million Under EB-5 Capital Program
Capital raised from EB-5 Program projected to generate over 7,100 direct and induced jobs in New Mexico and across the U.S.

Funds will be used to further develop Bright Green’s world-class production and drug manufacturing facilities in New Mexico, as well as to support drug research, development, and associated FDA clinical trials

Bright Green to issue stock through EB-5 Program at a price of $39.99 per share, subject to customary regulatory approvals

https://ca.finance.yahoo.com/news/bright-green-announces-plans-raise-140000169.html

[solidgold]

Hi here, GLTY with BGXX which could be a big winner in time.

[harry crumb]

Out, thanx. Gl to all. Careful

[Jess070283]

500 million…. This baby running!$$$

[makinezmoney]

$BGXX: $1.80............. YYYEEEEEEEEEowwwwwwwwwwwwwwwww

KILLIN IT !!!!!!!!!!!


Bring us $2 break baby



GO $BGXX

[harry crumb]

Rippn

[Penny chatter]

Lol 39.99
https://finance.yahoo.com/news/bright-green-announces-plans-raise-140000169.html?guccounter=1

[ZigZag1]

Take the money and run!

[makinezmoney]

$BGXX: SOooooooooooooo strong today... now $1.40


Helluva intraday runner here


GGOooooooooooo babyyyyyyyyyy



GO $BGXX

[ZigZag1]

Just a tiny resistance at best.

[Penny chatter]

Ruski!!!

[Penny chatter]

This one wiped out everyone of you?

[ALERTS100%to10000%GAIN]

BGXX~~a small resistance at $2.07 and nothing to $7.00 ,is freaking huge here

[ALERTS100%to10000%GAIN]

was a opp to sell at 2.10++after 7am

[PStockPickz]

Back in $1.76 hopefully they let this breathe

[ALERTS100%to10000%GAIN]

BGXX~1.77,~MA50 @ $1.75, and blue SKY~~https://stockcharts.com/h-sc/ui?s=bgxx&p=D&yr=0&mn=6&dy=0&id=p06455731712

[ALERTS100%to10000%GAIN]

anyone sold at $3.0+++in PM

[ALERTS100%to10000%GAIN]

looks great fellas

[PStockPickz]

Someone's really blowing out what of been a nice runner. $3.50 prints and they selling 1.80 hours later

[INFINITI]

Looks good here $$

[Mr Krabs]

You have my full attention mate

[ALERTS100%to10000%GAIN]

BGXX~~WAS $58.00 PPS now is $1.30 pps, could go 3,000%% upside here,,https://stockcharts.com/h-sc/ui?s=bgxx&p=D&yr=0&mn=6&dy=0&id=p06455731712

[ALERTS100%to10000%GAIN]

better load at $1.30 now BGXX

[ALERTS100%to10000%GAIN]

BGXX~1.30~better load asap now,look here,,https://stockcharts.com/h-sc/ui?s=bgxx&p=D&yr=0&mn=6&dy=0&id=p31873288935

[ALERTS100%to10000%GAIN]

BGXX~~WOWWW,ADX (14)~ chart,huge bottom oversold, https://stockcharts.com/h-sc/ui?s=bgxx&p=D&yr=0&mn=6&dy=0&id=p46634481126

[ALERTS100%to10000%GAIN]

BGXX~~1.30,huge breakout to $5.0++,,https://stockcharts.com/freecharts/gallery.html?bgxx

[ALERTS100%to10000%GAIN]

BGXX~~1.30 ah load fast fellas.26%% up

[Scumbag Fraudsters]

Ditto Akanda.

[ZigZag1]

They’re going be in price default at this rate. This stock is like a prank gone bad!

[Scumbag Fraudsters]

They beat Akanda.

Akanda's IPO on March 15th opened at $30 and closed at $10.50.

One month later it closed @ $9.87. That's a loss of 67%.

It's been trading this month under 80¢.

That's what happens when a dumbass CEO goes ahead with an IPO during the worst IPO quarter in 6 years.


Bright Green's $58 to $2 drop is a 96.5% loss.

[ZigZag1]

Maybe I am misreading things; but looking at the share price I don’t think I’m the only one. There may be 15 licenses granted for this specific program, but we have had our schedule 1 for about 22 years. It’s really not that big of a deal. $58 to $2 in a month may be a record!

[Scumbag Fraudsters]

I think you're totally misreading things.

Neither the Benzinga article or prospectus say they were "chosen." Approved yes, chosen NO.

It's not a drawing, but not everyone who applies for a license will be granted one, either. There are countless growers, but less than two-dozen licenses up for grabs.

Did you gloss over this part?

The DEA’s Final Rule on the topic estimated that it would award between three and fifteen companies with these registrations. BGC will produce cannabis in full compliance with all federal, state, and local laws for the U.S. government and pharmaceutical producers of medicinal cannabis products who are also licensed by the DEA.

That says only a select few (up to about 15) companies will be approved to grow cannabis for research.

Some growers will undoubtedly fall short in areas like security, experience or quality control, and their applications will be denied. Or maybe they just didn't apply early enough and the slots were already filled.

So yes - approval is a significant achievement. It's fair to say they were chosen, selected or picked. Their application could just as easily been turned down, especially since their facility wasn't even constructed or operational yet.

And it's no small feat when you consider that there are thousands of growers across the U.S.

Here's a list of 10 grow projects slated for construction this year. How many of them do you think hold DEA licenses?

Bright Green's site is being constructed from the ground up to meet the DEA's stringent requirements. If they fail to meet those requirements at any time, their license may be in danger of revocation.


After reading further, I see they intend to not only grow plants for outside labs, but will be conducting research themselves as well as developing their own medical products.

Upon receipt of final registration from the DEA as described above, we plan to cultivate and manufacture cannabis for federally sanctioned research, as well as perform authorized research on cannabis, including but not limited to CBN, CBG, and CBD. We also plan to leverage our cultivation, research, and manufacturing facilities to develop and commercialize approved medical cannabis products to sell to DEA registered pharmaceutical producers.

[Scumbag Fraudsters]

That's Benzinga's headline! The company never said it! (unless you can show me otherwise).

There's a difference between an official company PR and one from an independent source. Not saying one is better than the other - often it's the official ones that are the most misleading and damaging.

That kind of DD might explain why you're underwater on your investments (I'm drowning with you).

July 22, 2022

Great! This 25% increase brings us all the way up to only an 80% loss on the 52 week!

Investors might want to heed the warnings in the article.

Dr. Sue Sisley, head of the Scottsdale Research Institute, which is among the DEA cannabis cultivation registrants, said business models based on the DEA registrations are bound to fail.

“The entities who are trying to build a business model around these few research registrations won’t be successful. The demand for research cannabis is minimal,” Sisley said, per MJBiz.

“This is not a lucrative business model and never will be. It takes over 10 years to develop drugs that get FDA approval – and is massively more complicated when it comes to agricultural products that have complex chemical composition with tons of different bioactive molecules.”

I agree with the dr. about the demand for research cannabis being minimal - labs don't need to order hundreds of pounds of it at a time.

I did not read the entire prospectus, but I didn't see anything about them exclusively selling to DEA-approved labs, so perhaps the company can sell the majority of its harvests to distributors for dispensary sales.

I hope that's the case because from the photos I saw it looks like an impressive grow site. They can grow much more than is needed for research, and they're not the only DEA-approved grower supplying researchers.

But their DEA agreement may forbid selling to anyone other than DEA-approved facilities. Perhaps their contracts allow them to sell to researchers for a fixed rate of something like $3000 per pound since they're one of the few approved growers.


If you're PPS is around $2, you might be okay in the long run. But if you've ridden it down from IPO prices, you might want to think long & hard about getting out with $2 per share before it falls any lower.

https://ih.advfn.com/stock-market/NASDAQ/bright-green-BGXX/chart

[ZigZag1]

If you read down a bit, it also says the were “chosen”. This isn’t a drawing, it’s a simple application to get the license. The DEA doesn’t “choose” anybody. There is so many twists in their PR’s that don’t need to be there. I feel that if they kept these things out, the stock would be at $5.

[ZigZag1]

https://www.benzinga.com/markets/cannabis/22/05/27267955/dea-endorsed-cannabis-grower-makes-history-as-first-plant-touching-firm-on-nasdaq-shares-soared

[Scumbag Fraudsters]

Bright Green Announces CEO Transition

https://www.otcmarkets.com/stock/bgxx/news/story?e=&id=2253990

Somehow that missed being posted.

[Scumbag Fraudsters]

Where did you read that the company said the DEA "endorsed" them?

I just searched the prospectus and June 28th PR and didn't see the word "endorse" (or its variants) anywhere.

They not only paid filing fees, but had already been "selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products"

On May 14, 2021, the DEA announced that it planned to provide memorandums of agreement to an unspecified and unnamed number of companies to collaborate with the DEA “to facilitate the production, storage, packaging, and distribution of marijuana under the new regulations as well as other applicable legal standards and relevant laws.” The DEA’s final rule on the topic estimated that it would award licenses to between three and fifteen companies. To the extent these memorandums of agreement are finalized, the DEA anticipates issuing DEA registrations to these manufacturers. Each applicant will then be authorized to cultivate cannabis – up to an allotted quota – in support of the more than 575 DEA-licensed researchers across the nation.

Where's the license? I don't see a link posted.

Am I missing something?

Why would it matter if the co's license isn't for THC? The products approved by the FDA thus far don't contain THC anyway. Marinol and Syndros both contain a synthetic version of THC (delta-9-THC).

As long as those "more than 575 DEA-licensed researchers" are buying the company's plants, who cares what they extract from them?

In fact, while most pot co's are concentrating on achieving maximum THC levels, that may not be a factor here.

[ZigZag1]

My point is not if they have a license (I have a DEA license), but they use the word “cannabis” over and over. It’s only when you dive deeper that you will see that it’s not for THC, the way they are selling it, but only for CBD, CBN and CBN, all things you can get online. The license they have is nothing special, it only means they paid the filing fees. I think the share price sparkly for itself. I think that is because people dig a little deeper and found 99% of what they claimed was twisted.

[Scumbag Fraudsters]

This DEA fact sheet from 2020 states that even though the FDA has approved several cannabis-based medications, none have been approved for clinical indication and cannabis remains illegal. shorturl.at/ceMS5

"Consistent therewith, the FDA and DEA have concluded that marijuana has no federally approved medical use for treatment in the U.S. and thus it remains as a Schedule I controlled substance under federal law."


They awkwardly claim there is "no currently accepted medical use in treatment in the United States," despite several drugs having already been approved for use:

Marinol was approved by the FDA in 1985.

Syndros was approved by the FDA in 2016.

Epidiolex was approved by the FDA in 2018

Marinol is a synthetic version of THC in a capsule (also referred to as dronabinol, the generic or International Nonproprietary Name given to THC), prescribed for the control of nausea and vomiting caused by chemotherapeutic agents used in the treatment of cancer and to stimulate appetite in acquired immune deficiency syndrome (AIDS) patients. Marinol is a Schedule III drug under the Controlled Substances Act.

Syndros is an oral dronabinol (THC) solution that is used for the treatment of anorexia associated with weight loss in patients who have failed to respond adequately to conventional antiemetic treatments. Syndros is a Schedule II drug under the Controlled Substances Act.

Epidiolex is an oral solution of cannabidiol (CBd) that has no more that 0.1% THC, used to treat two epilepsy conditions, Dravet syndrome and Lennox-Gestaut syndrome. Epidiolex is a Schedule V drug under the Controlled Substances Act.